drugset / Trial / NCT01647893
Phase 1 Single Dose Escalation Study of CTB-001
RandomizedParallel-groupTriple-blindSupportive care
Summary
A Phase 1 Clinical Study, Randomized, Double-blind, Placebo-controlled, Single-dose, Dose Escalation Study of the Safety and Pharmacokinetic/Pharmacodynamic Profiles of CTB-001 Intravenously Administered in Healthy Male Subjects
Timeline
- Start
- 2012-07
- Primary completion
- 2012-11
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CTB-001 | Unknown | 0.375 mg/kg | Intravenous |
| Subject | CTB-001 | Unknown | 0.75 mg/kg | Intravenous |
| Subject | CTB-001 | Unknown | 1.5 mg/kg | Intravenous |
Indications
No indication recorded.